טוען...
End-point Modification of Recombinant Thrombomodulin with Enhanced Stability and Anticoagulant Activity
Thrombomodulin (TM) is an endothelial cell membrane protein that plays essential roles in controlling vascular haemostatic balance. The 4, 5, 6 EGF-like domain of TM (TM(456)) has cofactor activity for thrombin binding and subsequently protein C activation. Therefore, recombinant TM(456) is a promis...
שמור ב:
| הוצא לאור ב: | Eur J Pharm Sci |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6767613/ https://ncbi.nlm.nih.gov/pubmed/31513922 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejps.2019.105066 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|